Skip Navigation


QJM Advance Access originally published online on April 25, 2008
QJM 2008 101(7):593-594; doi:10.1093/qjmed/hcn059
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
101/7/593    most recent
hcn059v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Jolobe, O.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jolobe, O.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

The use of the sliding scale also needs to be reviewed

The first 10% of the full text of this article appears below.

Sir,

Apart from the issue of administration of intravenous insulin to patients who are able to eat normally, and in whom subcutaneous insulin is not contraindicated1 the other consideration worth addressing is the continuing prevalence of the sliding scale insulin (SSI) regime in clinical practice, exemplified by its use, albeit via intravenous infusion, in 10 of the patients in the study.1 This should be a cause of concern, given the fact . . . [Full Text of this Article]

O. Jolobe

Medical Division
Manchester Medical Society
C/o John Rylands University Library
Oxford Road
Manchester M13 9PP
email: oscarjolobe@yahoo.co.uk


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?